UK Health Department Introduces Drug Price-Control Bill

The UK’s Department of Health has introduced a bill that would allow the government to better control the price of medicines.

The Health Service Medical Supplies Bill would require manufacturers, distributors and others involved in drug pricing to provide the UK’s Secretary of State with information on drugs that have experienced significant price hikes to allow the government to address price gouging.

The bill is intended to better align existing regulatory frameworks to improve the government’s oversight on drug prices.